BiotechTube

Brivaracetam Film-coated tablet + Brivaracetam oral solution

Phase 3Recruiting
1 views this week 0 watching⚡ Active
Interest: 47/100
47
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Childhood Absence Epilepsy

Conditions

Childhood Absence Epilepsy, Juvenile Absence Epilepsy

Trial Timeline

Jul 10, 2024 → Mar 1, 2030

NCT ID
NCT06315322

About Brivaracetam Film-coated tablet + Brivaracetam oral solution

Brivaracetam Film-coated tablet + Brivaracetam oral solution is a phase 3 stage product being developed by UCB for Childhood Absence Epilepsy. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06315322. Target conditions include Childhood Absence Epilepsy, Juvenile Absence Epilepsy.

What happened to similar drugs?

1 of 4 similar drugs in Childhood Absence Epilepsy were approved

Approved (1) Terminated (0) Active (3)
🔄Obinutuzumab + MMF + Prednisone + Methylprednisolone + Acetaminophen/ Paracetamol + Diphenhydramine HydrochlorideRochePhase 3
✅SemaglutideNovo NordiskApproved
🔄Brivaracetam Film-coated tablet + Brivaracetam oral solutionUCBPhase 3
🔄BrivaracetamUCBPhase 3

Hype Score Breakdown

Clinical
17
Activity
15
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT06315322Phase 3Recruiting
NCT05109234Phase 3Completed

Competing Products

20 competing products in Childhood Absence Epilepsy

See all competitors
ProductCompanyStageHype Score
LY2940680 + LY2940680Eli LillyPhase 1
21
Panobinostat + Cytarabine + PanobinostatNovartisPhase 1
29
Obinutuzumab + MMF + Prednisone + Methylprednisolone + Acetaminophen/ Paracetamol + Diphenhydramine HydrochlorideRochePhase 3
44
Rituximab + PlaceboRochePhase 2/3
38
BlinatumomabAmgenPhase 2
27
SemaglutideNovo NordiskApproved
50
Temsirolimus + Etoposide + Cyclophosphamide + Methotrexate + Hydrocortisone + CytarabinePfizerPhase 1
29
Talazoparib + Irinotecan + Temozolomide + Filgrastim + Peg-filgrastimPfizerPhase 1
29
CrizotinibPfizerPhase 1/2
32
Nivolumab + 5-azacytidineBristol Myers SquibbPhase 1/2
28
carboplatin + irinotecan hydrochlorideBristol Myers SquibbPhase 1
29
Vinblastine + Cyclophosphamide + Capecitabine + NivolumabBristol Myers SquibbPhase 1/2
36
Paxalisib + Opdualag + Irinotecan (drug) + Temozolomide (TMZ)Bristol Myers SquibbPhase 1/2
39
Clofarabine incorporated into a 5-drug regimenSanofiPhase 1
29
Brivaracetam Film-coated tablet + Brivaracetam oral solutionUCBPhase 3
40
BrivaracetamUCBPhase 3
44
Sodium OxybateJazz PharmaceuticalsPhase 1/2
29
Modified Measles Virus + Modified Measles Virus Lumbar PunctureBrain BiotechPhase 1
19
palbociclib isethionateBrain BiotechPhase 1
11
Cytarabine + Fludarabine + Hydrocortisone Sodium Succinate + Imetelstat + Leucovorin Calcium + MethotrexateGeronPhase 1
30